ATE216237T1 - Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade - Google Patents

Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Info

Publication number
ATE216237T1
ATE216237T1 AT94919912T AT94919912T ATE216237T1 AT E216237 T1 ATE216237 T1 AT E216237T1 AT 94919912 T AT94919912 T AT 94919912T AT 94919912 T AT94919912 T AT 94919912T AT E216237 T1 ATE216237 T1 AT E216237T1
Authority
AT
Austria
Prior art keywords
ropivacaine
pct
analgesic
produce
minimal motor
Prior art date
Application number
AT94919912T
Other languages
English (en)
Inventor
Arne Torsten Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216237(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE216237T1 publication Critical patent/ATE216237T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Steroid Compounds (AREA)
  • Air Conditioning Control Device (AREA)
  • Electromechanical Clocks (AREA)
  • Particle Accelerators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94919912T 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade ATE216237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (1)

Publication Number Publication Date
ATE216237T1 true ATE216237T1 (de) 2002-05-15

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919912T ATE216237T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Country Status (33)

Country Link
US (2) US5670524A (de)
EP (1) EP0706395B1 (de)
JP (1) JP3725541B2 (de)
CN (1) CN1074918C (de)
AT (1) ATE216237T1 (de)
BR (1) BR9406865A (de)
CA (1) CA2165446C (de)
CZ (1) CZ283300B6 (de)
DE (2) DE69430427T2 (de)
DK (1) DK0706395T3 (de)
EE (1) EE03205B1 (de)
ES (1) ES2099048T3 (de)
FI (1) FI956269A (de)
GR (1) GR970300013T1 (de)
HK (1) HK1010344A1 (de)
HU (1) HU218949B (de)
IL (1) IL110006A (de)
IS (1) IS4174A (de)
LT (1) LT3449B (de)
LV (1) LV12918B (de)
MY (1) MY119360A (de)
NO (1) NO955313L (de)
NZ (1) NZ268110A (de)
PH (1) PH31258A (de)
PL (1) PL175518B1 (de)
PT (1) PT706395E (de)
RU (1) RU2152215C1 (de)
SA (1) SA94150010B1 (de)
SE (1) SE9302218D0 (de)
SG (1) SG49078A1 (de)
SK (1) SK280111B6 (de)
TW (1) TW285640B (de)
WO (1) WO1995000148A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
WO1999004771A2 (en) * 1997-07-21 1999-02-04 Darwin Discovery Limited Use of levobupivacaine
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
USRE46397E1 (en) 2007-11-07 2017-05-09 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ, インク.Dermira, Inc. グリコピロレート塩
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (de) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipekolsäure-2,6-xylidid und dessen herstellung
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
DE69430427T2 (de) 2002-11-14
DK0706395T3 (da) 2002-07-22
AU7086694A (en) 1995-01-17
DE706395T1 (de) 1997-09-04
ES2099048T3 (es) 2002-11-16
EE03205B1 (et) 1999-08-16
IL110006A0 (en) 1994-11-11
DE69430427D1 (de) 2002-05-23
IL110006A (en) 1999-01-26
HUT75115A (en) 1997-04-28
CZ336495A3 (en) 1996-06-12
NZ268110A (en) 1999-06-29
GR970300013T1 (en) 1997-05-31
SK280111B6 (sk) 1999-08-06
SK164695A3 (en) 1996-07-03
PT706395E (pt) 2002-09-30
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
US5834489A (en) 1998-11-10
LT3449B (en) 1995-10-25
LV12918B (en) 2003-03-20
IS4174A (is) 1994-12-29
CA2165446C (en) 2005-07-05
TW285640B (de) 1996-09-11
SA94150010B1 (ar) 2006-04-04
HU9503692D0 (en) 1996-02-28
HU218949B (hu) 2001-01-29
SG49078A1 (en) 1998-05-18
CA2165446A1 (en) 1995-01-05
PH31258A (en) 1998-06-18
CN1074918C (zh) 2001-11-21
EP0706395B1 (de) 2002-04-17
LTIP1958A (en) 1995-01-31
FI956269A0 (fi) 1995-12-27
RU2152215C1 (ru) 2000-07-10
ES2099048T1 (es) 1997-05-16
FI956269A (fi) 1995-12-27
CZ283300B6 (cs) 1998-02-18
NO955313D0 (no) 1995-12-27
PL175518B1 (pl) 1999-01-29
JPH09500620A (ja) 1997-01-21
WO1995000148A1 (en) 1995-01-05
EP0706395A1 (de) 1996-04-17
NO955313L (no) 1995-12-27
BR9406865A (pt) 1996-03-26
MY119360A (en) 2005-05-31
JP3725541B2 (ja) 2005-12-14
SE9302218D0 (sv) 1993-06-28
AU692161B2 (en) 1998-06-04
HK1010344A1 (en) 1999-06-17
US5670524A (en) 1997-09-23

Similar Documents

Publication Publication Date Title
MY115662A (en) Novel compounds with analgesic effect
ATE174508T1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
ATE216237T1 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
ATE200423T1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3- trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
ATE283272T1 (de) Morphine derivate mit analgetischen eigenschaften
ATE220904T1 (de) 2-phenyl-3-azoylbenzothiophene zur erhöhung der thrombomodulin expression
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
DE69626301D1 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
ATE240101T1 (de) Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
DE68910010D1 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
ATE200623T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie
MX9804797A (es) Nuevos compuestos con efecto analgesico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee